Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

Nvidia introduced the Blackwell Ultra and Vera Rubin, its most powerful AI chips to date, amid escalating demand for AI ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Americans are running out of time to claim a $1,400 stimulus check. Tuesday marks Tax Day as well as the three-year deadline ...

Doctors have explained the potential pros and cons of these so-called 'skinny jabs', with everything from nausea to abdominal ...

From outer space threats to dangerous dino drama — from super-powered action to robotic horror — and from mega-budget ...

Researchers have added to fears around the drug, however, after calling for ‘urgent attention’ following a discovery that ...

The electric-vehicle maker will report results after markets close. Analysts expect a year-over-year drop in profit, FactSet estimates show. Tesla stock, which has fallen 44% this year through Monday, ...

Given the lack of precedence, they remain a bit of a wild card. Perlman pointed out that every new administration has its priorities, including healthcare-related. What’s unprecedented is the ...

A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood ...

Ozempic, a medication to help manage diabetes, has shot up in popularity in the US. So much so, that the US Food and Drug Administration (FDA) has issued a warning against using counterfeit Ozempic, ...